iLet Bionic Pancreas, REF: BB1001

FDA Device Recall #Z-1996-2026 — Class II — March 12, 2026

Recall Summary

Recall Number Z-1996-2026
Classification Class II — Moderate risk
Date Initiated March 12, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Beta Bionics, Inc.
Location Irvine, CA
Product Type Devices
Quantity 1,080

Product Description

iLet Bionic Pancreas, REF: BB1001

Reason for Recall

insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia.

Distribution Pattern

US Nationwide distribution in the states of TX, PA, AL, MI, OH, FL, TN, GA.

Lot / Code Information

Software versions 1.4.3, and 1.4.2

Other Recalls from Beta Bionics, Inc.

Recall # Classification Product Date
Z-1809-2026 Class II iLet Ace Pump Kit REF: BB1001 iLet Dosing Decis... Aug 13, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.